Generalizability and variability in tranexamic acid dosage and efficacy in postpartum haemorrhage
This systematic review and meta-analysis of 63 studies confirms that tranexamic acid effectively reduces postpartum blood loss, with efficacy varying by dosage regimen, delivery mode, and bleeding risk, showing the greatest benefit in cesarean deliveries and lower-risk populations.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Every year, more than one hundred thousand mothers die from bleeding after giving birth. This is a tragedy that happens most often in developing nations, but it remains a global emergency. When a woman delivers a baby, her body must quickly stop the bleeding that naturally occurs as the placenta separates. Sometimes, the uterus does not contract strongly enough to close off the blood vessels, or the blood's ability to clot is disrupted. In these moments, time is critical. Doctors have long relied on drugs that make the uterus squeeze tighter, but there is another tool in the medical kit: a medicine called tranexamic acid. This drug works differently; instead of squeezing the uterus, it helps the blood's own clotting system work faster and stronger, preventing the blood from breaking down too quickly. While doctors know this drug helps, they have been unsure about the perfect way to use it. Should everyone get the same amount, or does the dose need to change depending on how the baby is born or how much risk the mother faces?
A team of researchers from Nigeria and other institutions set out to answer these questions by gathering and analyzing data from sixty-three different studies involving over seven thousand women. They looked at trials where some women received tranexamic acid and others did not, comparing how much blood was lost in each group. The researchers found that the drug is indeed highly effective at reducing blood loss. On average, women who received the medicine lost significantly less blood than those who did not. However, the story is not as simple as "one size fits all." The researchers discovered that the drug worked even better when given to women having a planned cesarean section compared to those having a vaginal birth. Furthermore, the way the drug was administered mattered greatly. In the studies where doctors gave a dose calculated by the woman's weight—specifically a loading dose followed by a continuous drip—the reduction in blood loss was much larger than in studies where everyone received a single, fixed amount of one gram.
The analysis also revealed that the setting of the study influenced the results. Studies conducted in high-income countries showed a smaller benefit from the drug compared to those in low- and middle-income countries. The researchers suggest this might be because the women in the wealthier countries' studies were less likely to be at high risk of bleeding to begin with, whereas the drug's effect appeared smaller in groups with a higher proportion of women at high risk of bleeding. Another key finding was that the drug's power seems to depend on the specific dosage regimen. The most dramatic improvements were seen when the medicine was given as a weight-based loading dose followed by an infusion, rather than a standard fixed dose. This suggests that the current global recommendation, which often suggests a flat dose for everyone, might not be the most effective strategy for every situation.
The researchers did not find that the drug was dangerous in these studies, but they emphasized that the timing of the dose is crucial. The benefit of the medicine drops significantly if it is delayed, with the best results seen when it is given as soon as bleeding is noticed. The team concluded that while tranexamic acid is a powerful tool for saving lives, medical guidelines should evolve to reflect these nuances. They argue that doctors should consider the mother's weight, her risk of bleeding, and the type of delivery when deciding on the dose. Instead of a single fixed amount for every woman, a tailored approach using a weight-based loading dose followed by an infusion appears to offer the greatest protection, particularly in lower-risk populations and cesarean deliveries. This detailed look at the evidence suggests that to truly master the fight against postpartum bleeding, medicine must move beyond a one-size-fits-all approach and embrace a more precise, personalized strategy.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.